Apolipoprotein A-I Mimetic Peptides for the Treatment of Coronary Artery Disease

By  

Current Cardiology Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 81-84

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Altered Apolipoprotein A-I Structure on Plasma HDL Concentration

By Sorci-Thomas M.G.   Thomas M.J.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 3, 2002-04 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties

By Hoang A.   Murphy A.   Coughlan M.   Thomas M.   Forbes J.   O’Brien R.   Cooper M.   Chin-Dusting J.   Sviridov D.  

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1770-1779

Springer Publishing Company

Access to resources Recommend Favorite

Proteomic Identification of Lower Apolipoprotein A-I in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 155-161

Karger

Access to resources Recommend Favorite

Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits

By Shimoji E.   Zhang B.   Fan P.   Saku K.  

Atherosclerosis, Vol. 172, Iss. 2, 2004-02 ,pp. : 247-257

Elsevier

Access to resources Recommend Favorite